Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer

Clinical trial NCT07230080 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07230080
Sponsor: Nanfang Hospital, Southern Medical University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

HCC - Hepatocellular Carcinoma SBRT TACE Immunotherapy Targeted Therapy

Start date: 2024-09-01
Primary completion: 2025-11-20
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.